# ANI Pharmaceuticals to Present at September Investor Conferences
Canonical URL: https://biopharmsignal.com/news/ANIP/ani-pharmaceuticals-to-present-at-september-investor-conferences-9c102b8f
Ticker: ANIP
Company: ANI Pharmaceuticals
Source: ANI Pharmaceuticals
Published: 2026-09-03 10:55 EST
## Summary

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Nikhil Lalwani,...

## Article Body
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership team, will participate in fireside chats at the following upcoming investor conferences:

| Event | 2026 Wells Fargo Healthcare Conference |
| --- | --- |
| Date | Thursday, September 10, 2026 |
| Time | 1:30 p.m. ET |
| Webcast | Click here |
| Event | Morgan Stanley 24th Annual Global Healthcare Conference |
| Date | Monday, September 14, 2026 |
| Time | 7:00 a.m. ET |
| Webcast | Click here |
| Event | H.C. Wainwright 28th Annual Global Investment Conference |
| Date | Tuesday, September 15, 2026 |
| Time | 12.00 p.m. ET |
| Webcast | Click here |

The live and archived webcasts will also be accessible from the Company’s website at www.anipharmaceuticals.com , in the Investors section under Events and Presentations.

About ANI

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit https://www.anipharmaceuticals.com.

Investor Relations: Irina Koffler, Vice President, Investor Relations T: 917-734-7387 E: Irina.koffler@anipharmaceuticals.com

Media Relations: Argot Partners T: 212-600-1494 E: ani@argotpartners.com

SOURCE: ANI Pharmaceuticals, Inc.
## Recent Company News
- 2026-09-03 10:55 EST — [ANI Pharmaceuticals to Present at September Investor Conferences](https://biopharmsignal.com/news/ANIP/ani-pharmaceuticals-to-present-at-september-investor-conferences-9c102b8f) — Source: ANI Pharmaceuticals
- 2026-08-24 10:55 EST — [ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors](https://biopharmsignal.com/news/ANIP/ani-pharmaceuticals-appoints-henry-gosebruch-to-board-of-directors-98e272ac) — Source: ANI Pharmaceuticals
- 2026-08-07 10:50 EST — [ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/ANIP/ani-pharmaceuticals-reports-record-second-quarter-2026-financial-results-68f15c4b) — Source: ANI Pharmaceuticals
- 2026-07-24 10:50 EST — [ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET](https://biopharmsignal.com/news/ANIP/ani-pharmaceuticals-to-discuss-second-quarter-2026-financial-results-on-august-7-f8a7cc57) — Source: ANI Pharmaceuticals
- 2026-07-16 20:34 EST — [ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter](https://biopharmsignal.com/news/ANIP/ani-pharmaceuticals-announces-intent-to-appeal-rulings-in-cg-oncology-matter-62a30dad) — Source: ANI Pharmaceuticals
## Related News
- 2026-09-09 23:25 EST — IRON — [Disc Medicine Presents Initial Results from RESTORE-PV Phase 2 Trial in Patients with Polycythemia Vera (PV) at the 14th Society of Hematologic Oncology (SOHO) Annual Meeting](https://biopharmsignal.com/news/IRON/disc-medicine-presents-initial-results-from-restore-pv-phase-2-trial-in-patients-718b0075)
- 2026-09-09 20:17 EST — COO — [CooperCompanies Announces Third Quarter 2026 Results](https://biopharmsignal.com/news/COO/coopercompanies-announces-third-quarter-2026-results-0256684b)
- 2026-09-09 20:15 EST — COO — [CooperCompanies Completes Strategic Review, Increases Share Repurchase Authorization](https://biopharmsignal.com/news/COO/coopercompanies-completes-strategic-review-increases-share-repurchase-authorizat-c3b7ff3b)
- 2026-09-09 20:15 EST — NBTX — [NANOBIOTIX Participera à la Conférence H.C. Wainwright 28th Annual Global Investment](https://biopharmsignal.com/news/NBTX/nanobiotix-participera-la-conf-rence-h-c-wainwright-28th-annual-global-investmen-8b1208fb)
- 2026-09-09 20:15 EST — NBTX — [NANOBIOTIX to Participate in the H.C. Wainwright 28th Annual Global Investment Conference](https://biopharmsignal.com/news/NBTX/nanobiotix-to-participate-in-the-h-c-wainwright-28th-annual-global-investment-co-bd8b771d)